Skip to main content
. 2020 Feb 25;11(4):1052–1060. doi: 10.1111/1759-7714.13364

Figure 1.

Figure 1

Rate of progression‐free survival (PFS) in the study population. Kaplan‐Meier curves are shown for progression‐free survival. (a) Inline graphic Median PFS for overall patients. (b) median PFS, Inline graphic line; ILD, Inline graphic line; irAEs‐non‐ILD, Inline graphic line; non‐irAEs. ILD, interstitial lung disease; irAEs, immune‐related adverse events; NR, not reached.